Pharmacist Interventions n (%) Pharmacist Interventions n (%) Pharmacist Interventions n (%)
Prior to COVID-19 (n=54) During COVID-19 (n=177) p-value
Drug-related issues
Adverse drug reaction 0 1 (0.6%) 1.000
Drug monitoring 2 (3.7%) 2 (1.1%) 0.234
Drug without indication 18 (33.3%) 30 (16.9%) 0.013
Failure to receive a drug 0 1 (0.6%) 1.000
Improper administration 5 (9.3%) 42 (23.7%) 0.021
Non conformity to guidelines or contraindication 13 (24.1%) 41 (23.2%) 0.857
Subtherapeutic dosage 5 (9.3%) 3 (1.7%) 0.019
Supratherapeutic dosage 11 (20.4%) 51 (28.8%) 0.292
Untreated indication 0 6 (3.4%) 0.340
Therapeutic advice
Addition of a new drug 2 (3.7%) 16 (9.0%) 0.257
Administration modalities optimisation 1 (1.9%) 27 (15.3%) 0.007
Change of administration route 2 (3.7%) 8 (4.5%) 1.000
Dose adjustment 13 (24.1%) 44 (24.9%) 1.000
Drug discontinuation 26 (48.1%) 46 (26.0%) 0.004
Drug monitoring 2 (3.7%) 3 (1.7%) 0.333
Drug switch 8 (14.8%) 33 (18.6%) 0.684